SCHEMBL2225013

SCHEMBL2225013

CCc1csc(-c2ccc(F)cc2)n1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.62
RAB9A P51151 3/20 0.57
POLB P06746 3/20 0.57
NPC1 O15118 2/20 0.57
GAA P10253 2/20 0.57
KDM4E B2RXH2 3/20 0.51
AR P10275 1/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 4/20 0.49
TP53 P04637 2/20 0.49
SREBF2 Q12772 1/20 0.49
GFER P55789 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
TDP1 Q9NUW8 1/20 0.46
CYP19A1 P11511 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17130336 0.84 RAB9A (0.58) LMNARAB9APOLBNPC1GAA
SCHEMBL201736 0.82 GFER (0.72) LMNARAB9APOLBNPC1GAA
SCHEMBL2226112 0.82 LMNA (0.67) LMNAPOLBGAAKDM4EAR
SCHEMBL2056124 0.82 GFER (0.72) LMNARAB9APOLBNPC1GAA
SCHEMBL27306341 0.82 RAB9A (0.57) LMNARAB9APOLBNPC1GAA
SCHEMBL153338 0.81 HPGD (0.60) LMNARAB9APOLBNPC1GAA
SCHEMBL6760692 0.81 RAB9A (0.56) LMNARAB9APOLBNPC1GAA
SCHEMBL2056125 0.81 TP53 (0.55) LMNARAB9APOLBNPC1GAA
Bromide SCHEMBL9271730 0.81 RAB9A (0.55) LMNARAB9APOLBNPC1GAA
SCHEMBL18924618 0.80 SMN1; SMN2 (0.68) LMNAPOLBKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011088181-A9 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-01-31 WO disclosed
EP-2533783-A1 COMPOUNDS AND METHODS Tempero Pharmaceuticals, Inc. (US) 2012-12-19 EP disclosed
WO-2011088181-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2011-07-21 WO disclosed